tiprankstipranks
Renalytix AI Plc (GB:RENX)
LSE:RENX
Holding GB:RENX?
Track your performance easily

Renalytix AI (RENX) Share Price & Analysis

11 Followers

RENX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

16.10%0.05%83.86%
16.10% Insiders
0.05% Other Institutional Investors
83.86% Public Companies and
Individual Investors

RENX FAQ

What was Renalytix AI Plc’s price range in the past 12 months?
Renalytix AI Plc lowest share price was 6.50p and its highest was 74.90p in the past 12 months.
    What is Renalytix AI Plc’s market cap?
    Renalytix AI Plc’s market cap is $37.26M.
      When is Renalytix AI Plc’s upcoming earnings report date?
      Renalytix AI Plc’s upcoming earnings report date is Mar 27, 2025 which is in 56 days.
        How were Renalytix AI Plc’s earnings last quarter?
        Currently, no data Available
        Is Renalytix AI Plc overvalued?
        According to Wall Street analysts Renalytix AI Plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Renalytix AI Plc pay dividends?
          Renalytix AI Plc does not currently pay dividends.
          What is Renalytix AI Plc’s EPS estimate?
          Renalytix AI Plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Renalytix AI Plc have?
          Renalytix AI Plc has 331,206,020 shares outstanding.
            What happened to Renalytix AI Plc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Renalytix AI Plc?
            Currently, no hedge funds are holding shares in GB:RENX
            ---

            Company Description

            Renalytix AI Plc

            Renalytix AI PLC is a developer of artificial intelligence-enabled clinical decision support solutions for kidney disease and costly chronic medical conditions globally. The company's solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care, patient stratification for drug clinical trials, and drug target discovery.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Dialight
            Frontier IP
            Orosur Mining
            Tracsis
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis